TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND
US Patent
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND
US Patent
Affinity DataEC50: 17nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair